KLC1-ALK: A Novel Fusion in Lung Cancer Identified Using a Formalin-Fixed Paraffin-Embedded Tissue Only

• Yuki Togashi,

  Affiliations Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan, Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Manabu Soda,

  Affiliation Division of Functional Genomics, Jichi Medical University, Tochigi, Japan

  ⨯
• Seiji Sakata,

  Affiliation Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Emiko Sugawara,

  Affiliations Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan, Department of Comprehensive Pathology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan

  ⨯
• Satoko Hatano,

  Affiliations Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan, Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Reimi Asaka,

  Affiliations Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan, Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯
• Takashi Nakajima,

  Affiliation Division of Diagnostic Pathology, Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan

  ⨯
• Hiroyuki Mano,

  Affiliations Division of Functional Genomics, Jichi Medical University, Tochigi, Japan, Department of Medical Genomics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

  ⨯
• Kengo Takeuchi

  * E-mail: kentakeuchi-tky@umin.net

  Affiliations Pathology Project for Molecular Targets, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan, Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

  ⨯